Telescopic views (4 mm, 0°) of the right nasal cavity. A: Image shows a high septal deviation that has resulted in total obstruction of the superior nasal passage in a 47-year-old woman. B: Image shows a high septal deviation obstructing the sphenoethmoid recess in a 67-year-old man. Note the compressed polyp between the deviated septum (NS) and the supreme (sun), superior (ST), and middle turbinates (MT). SSO = sphenoid sinus ostium. Modified from Yanagisawa E.
Two patients came to the office with a high septal deviation that was associated with smell disturbance.
The first patient was a 47-year-old woman who complained of difficult nasal breathing, headaches, and intermittent anosmia associated with upper respiratory infections. A telescopic examination revealed an upper nasal airway obstruction that was caused by a marked superior deviation of the nasal septum on both sides and hypertrophy of the superior turbinates (figure, A). Computed tomography (CT) of the sinuses showed a marked pneumatization of the posterosuperior portion of the nasal septum, which was an anteroinferior extension of the sphenoid sinus. At surgery, the high septal deviation was found to be caused partly by a hyperpneumatization of the septum. The patient's smell sensation improved and her headaches resolved after an endoscopic surgical correction of her obstructive nasal septum.
The second patient was a 67-year-old man who complained of hyposmia, headaches, and nasal stuffiness associated with recurrent sinusitis. A telescopic examination revealed an almost total obstruction of the right upper nasal passage by a high septal deviation as well as an anteroinferior septal deformity (figure, B). He was also found to have a "compressed" polyp in the narrow space between the deviated septum and the supreme, superior, and middle turbinates. Septoplasty with an endoscopic excision of the high septal ridge and the sphenoethmoid recess polyps alleviated the patient's nasal obstruction, headaches, and smell disturbance. High nasal cavity obstruction can be difficult to diagnose by endoscopy during an office examination because oflimited accessibility. CT of the sinus is the most useful diagnostic tool for high septal deviation. Careful nasal endoscopy after nasal decongestion and topical anesthesia will confirm the diagnosis. The olfactory mucous membrane that contains the cells of origin of the olfactory nerve fibers is limited primarily to the region of the superior concha, a corresponding portion of the nasal septum, and the roof of the nasal cavity (the area of the cribriform plate).' Sufficient aeration to these areas might be hindered by the high septal deviation, its mucosal edema, or polyps in the superior nasal cavity, and can lead to an olfactory disturbance. These conditions might also obstruct the sphenoid sinus ostium and result in recurrent sphenoid sinusitis.
Effective treatment of the obstructive high septal deviation might require a careful endoscopic resection via the standard septoplasty approach and/or via an additional vertical septal incision just anterior to the obstruction." The surgeon must take care to avoid an injury to the cribriform plate. 
DESCRIPTION
Nystatin USP is an antifungal antibiotic obtained from Streptomyces noursei. It is known to be a mixture, but the composition has not been completely elucidated. Nystatin A is closely related to amphotericin B. Each is a macrocyclic lactone containing a ketal ring, an all-trans polyene system, and a mycosamine (3amino-3-deoxy-rhamnose) moiety. Nystatin A has a molecular formula of C47H75N017 and a molecular weight of 926.11 . Nystatin USP is a ready-to-use, non-sterile powder for oral administration which contains no excipients or preservatives. It is available in containers of 50 million, 150 million, 500 million, 2 billion, and 5 billion units. Each mg contains a minimum of 5,000 units.
CLINICAL PHARMACOLOGY
Nystatin probably acts by binding to sterols in the cell membrane of the fungus with a resultant change in membrane permeability allowing leakage of intracellular components. It is absorbed very sparingly following oral administration, with no detectable blood levels when given in the recommended doses. Most of the orally administered nystatin is passed unchanged in the stool. 
INDICATIONS FOR USAGE

ADVERSE REACTIONS
Large oral doses of nystatin have occasionally produced diarrhea, gastrointestinal distress, and possible irritation of the stomach that may result in nausea and vomiting.
DOSAGE AND ADMINISTRATION General
Adults and older children: Add 1/8 teaspoonful (approximately 500,000 units) of Nystatin USP to about 1/2 cup of water and stir well. One-eighth teaspoonful of Nystatin USP is equivalent to the recommended dose for adults and children of Nystatin Oral Suspension (4 to 6 mL, or 400,000 to 600,000 units). This product contains no preservatives and therefore should be used immediately after mixing and should not be stored. It is designed for extemporaneous preparation of a single dose at a time.
Infections of the oral cavitycaused by Candida (Monilia) albicans:
Infants: 200,000 units four times daily. Children and adults: 400,000 to 600,000 units four times daily (one-half dose in each side of mouth). NOTE: Limited clinical studies in premature and low birth-weight infants indicate that 100,000 units four times daily is effective. Local treatment should be continued at least 48 hours after perioral symptoms have disappeared and cultures returned to normal. It is recommended that the drug be retained in the mouth as long as possible before swallowing.
Intestinal candidiasis (moniliasis)
Usual dosage: 500,000 to 1 million units (approximately 1/8 to 1/4 teaspoonful) three times daily. Treatment should generally be continued for at least 48 hours after clinical cure to prevent relapse.
HOW SUPPLIED
Nystatin USP is supplied in containers of 50 million, 150 million, 500 million, 2 billion and 5 billion units. 
Product
NOTE:
The potency of this product cannot be assured for longer than 90 days after the container is first opened.
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